Bradley T Messmer
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.1MFederal grants as PI7 awards
1Patents grantedLatest Jun 20, 2023
64Papers2,810 citations
Federal awards and patents by year
AwardsPatents
7 awards · $3.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 11, 2020 | NIH | SBIR Phase II Personalized precision dosing of anti-TNF biologic therapies | $841K | ABREOS BIOSCIENCES, INC. |
| Aug 7, 2019 | NIH | SBIR Phase II Personalized precision dosing of biologic therapies in oncology | $1K | ABREOS BIOSCIENCES, INC. |
| Mar 6, 2019 | NIH | SBIR Phase II Personalized precision dosing of anti-TNF biologic therapies | $741K | ABREOS BIOSCIENCES, INC. |
| Aug 6, 2018 | NIH | SBIR Phase II Personalized precision dosing of biologic therapies in oncology | $720K | ABREOS BIOSCIENCES, INC. |
| Jan 25, 2018 | NIH | SBIR Phase II Personalized precision dosing of anti-TNF biologic therapies | $299K | ABREOS BIOSCIENCES, INC. |
| Aug 31, 2017 | NIH | SBIR Phase I Novel Materials for Viral Purification | $224K | ABREOS BIOSCIENCES, INC. |
| Aug 21, 2015 | NIH | STTR Phase I Novel Activin A Antagonists for Treatment of Osteoporosis | $225K | ABREOS BIOSCIENCES, INC. |
2 patents as inventor
- US 11680948ABREOS BIOSCIENCES, INC.Jun 20, 2023
- US ABREOS BIOSCIENCES, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#638
Awards as PI#280
Patents#284
Companies
- ABREOS BIOSCIENCES, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.